Skip to main content
SpringerLink
Log in

Intensive Immunosuppression Therapy for Aplastic Anemia Associated with Dyskeratosis Congenita

  • Letter to the Editor
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Comoli P, Basso S, Huanga GC. Intensive immunosuppression therapy for aplastic anemia associated with dyskeratosis congenita: report of a case. Int J Hematol. 2005;82:35–37.

    Article  Google Scholar 

  2. Drachtman RA, Alter BP. Dyskeratosis congenita: Clinical and genetic heterogeneity. Report of a new case and review of the literature. Am J Pediatr Hematol Oncol. 1992;14:297–304.

    Article  CAS  Google Scholar 

  3. Marrone A, Dokal I. Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer. Expert Rev Mol Med. 2004;6:1–23.

    Article  Google Scholar 

  4. Alter BP, Baerlocher G, Savage S, et al. Diagnosis of dyskeratosis congenita by telomere length. Pediatr Blood Cancer. 2005;44:537.

    Google Scholar 

  5. Baerlocher GM, Mak J, Tien T, Lansdorp PM. Telomere length measurement by fluorescence in situ hybridization and flow cytometry: tips and pitfalls. Cytometry. 2002;47:89–99.

    Article  CAS  Google Scholar 

  6. Marsh JC. Management of acquired aplastic anaemia. Blood Rev. 2005;19:143–151.

    Article  Google Scholar 

  7. Frickhofen N, Heimpel H, Kaltwasser JP, Schrezenmeier H, and the German Aplastic Anemia Study Group. Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia. Blood. 2003;101:1236–1242.

    Article  CAS  Google Scholar 

  8. Alter BP. Inherited bone marrow failure syndromes. In: Nathan DG, Orkin SH, Look AT, Ginsburg D, eds. Nathan and Oski’s Hematology of Infancy and Childhood. 6th ed. Philadelphia, PA: WB Saunders, 2003:280–365.

    Google Scholar 

  9. Alter BP, Gardner FH, Hall RE. Treatment of dyskeratosis congenita with granulocyte colony-stimulating factor and erythropoietin. Br J Haematol. 1997;97:309–311.

    Article  CAS  Google Scholar 

  10. Gungor T, Corbacioglu S, Storb R, Seger RA. Nonmyeloablative allogeneic hematopoietic stem cell transplantation for treatment of Dyskeratosis congenita. Bone Marrow Transplant. 2003;31:407–410.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. MPH, Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Blvd, Executive Plaza South, Room 7020, 20852-7231, Rockville, MD, USA

    Mohamad M. Al-Rahawan, Neelam Giri & Blanche P. Alter

  2. Children’s National Medical Center, Pediatric Hematology/Oncology, Center for Cancer and Blood Disorders, The George Washington University Medical Center, Washington, DC, USA

    Mohamad M. Al-Rahawan

Authors
  1. Mohamad M. Al-Rahawan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Neelam Giri
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Blanche P. Alter
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Blanche P. Alter.

About this article

Cite this article

Al-Rahawan, M.M., Giri, N. & Alter, B.P. Intensive Immunosuppression Therapy for Aplastic Anemia Associated with Dyskeratosis Congenita. Int J Hematol 83, 275–276 (2006). https://doi.org/10.1532/IJH97.06030

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1532/IJH97.06030

Keywords

Search

Navigation